205 related articles for article (PubMed ID: 18523071)
1. Tumor receptor imaging.
Mankoff DA; Link JM; Linden HM; Sundararajan L; Krohn KA
J Nucl Med; 2008 Jun; 49 Suppl 2():149S-63S. PubMed ID: 18523071
[TBL] [Abstract][Full Text] [Related]
2. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R
Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531
[TBL] [Abstract][Full Text] [Related]
3. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
de Visser M; Verwijnen SM; de Jong M
Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
[TBL] [Abstract][Full Text] [Related]
4. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor PET imaging with Gallium-68 labeled peptides.
Win Z; Al-Nahhas A; Rubello D; Gross MD
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):244-50. PubMed ID: 17464267
[TBL] [Abstract][Full Text] [Related]
6. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
8. Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging Studies.
Zeng C; McDonald ES; Mach RH
Handb Exp Pharmacol; 2017; 244():309-330. PubMed ID: 28176045
[TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
Mariani G; Erba PA; Signore A
J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
[No Abstract] [Full Text] [Related]
10. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.
Smith CJ; Volkert WA; Hoffman TJ
Nucl Med Biol; 2003 Nov; 30(8):861-8. PubMed ID: 14698790
[TBL] [Abstract][Full Text] [Related]
11. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.
Mankoff DA; Dehdashti F; Shields AF
Neoplasia; 2000; 2(1-2):71-88. PubMed ID: 10933070
[TBL] [Abstract][Full Text] [Related]
12. Receptor imaging: competitive or complementary to antibody imaging?
Goldsmith SJ
Semin Nucl Med; 1997 Apr; 27(2):85-93. PubMed ID: 9144853
[TBL] [Abstract][Full Text] [Related]
13. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging in oncology by means of nuclear medicine: fact or fiction?
Van de Wiele C
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):151-4. PubMed ID: 15129695
[No Abstract] [Full Text] [Related]
15. Molecular heterogeneity of somatostatin analogue BIM-23014C receptors in human breast carcinoma cells using the chemical cross-linking assay.
Prévost G; Lanson M; Thomas F; Veber N; Gonzalez W; Beaupain R; Starzec A; Bogden A
Cancer Res; 1992 Feb; 52(4):843-50. PubMed ID: 1346585
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography radiopharmaceuticals for sex steroid hormone receptor imaging.
Kiyono Y; Mori T; Okazawa H
Curr Med Chem; 2012; 19(20):3266-70. PubMed ID: 22664244
[TBL] [Abstract][Full Text] [Related]
17. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
[TBL] [Abstract][Full Text] [Related]
18. Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine.
Signore A; Chianelli M; Bei R; Oyen W; Modesti A
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):149-56. PubMed ID: 12520385
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
20. Isolation, characterization, and biological evaluation of syn and anti diastereomers of [(99m)Tc]technetium depreotide: a somatostatin receptor binding tumor imaging agent.
Cyr JE; Pearson DA; Nelson CA; Lyons BA; Zheng Y; Bartis J; He J; Cantorias MV; Howell RC; Francesconi LC
J Med Chem; 2007 Sep; 50(18):4295-303. PubMed ID: 17691760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
